ESSA Pharma (NASDAQ:EPIX) just reported results for the fourth quarter of 2023.
- ESSA Pharma reported earnings per share of -12 cents. This was above the analyst estimate for EPS of -21 cents.
- The company did not report any revenue for the quarter.
Source: iQoncept / Shutterstock
ESSA Pharma (NASDAQ:EPIX) just reported results for the fourth quarter of 2023.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/epix-stock-earnings-essa-pharma-for-q4-of-2023/.
©2025 InvestorPlace Media, LLC